These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29405507)

  • 1. Medicine-related beliefs predict attribution of symptoms to a sham medicine: A prospective study.
    Webster RK; Weinman J; Rubin GJ
    Br J Health Psychol; 2018 May; 23(2):436-454. PubMed ID: 29405507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Expectations of Side-Effects for Those Which Are Warned Versus Not Warned About in Patient Information Leaflets.
    Webster RK; Rubin GJ
    Ann Behav Med; 2021 Nov; 55(12):1253-1261. PubMed ID: 33821932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beliefs About Medicines Predict Side-Effects of Placebo Modafinil.
    Heller MK; Chapman SCE; Horne R
    Ann Behav Med; 2022 Oct; 56(10):989-1001. PubMed ID: 35512392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attribution-Based Nocebo Effects. Perceived Effects of a Placebo Pill and a Sham Magnetic Field on Cognitive Performance and Somatic Symptoms.
    Szemerszky R; Dömötör Z; Berkes T; Köteles F
    Int J Behav Med; 2016 Apr; 23(2):204-13. PubMed ID: 26420517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When symptoms become side effects: Development of the side effect attribution scale (SEAS).
    MacKrill K; Webster R; Rubin GJ; Witthöft M; Silvester C; Emad Y; Petrie KJ
    J Psychosom Res; 2021 Feb; 141():110340. PubMed ID: 33352479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beliefs about medication predict the misattribution of a common symptom as a medication side effect--Evidence from an analogue online study.
    Heller MK; Chapman SC; Horne R
    J Psychosom Res; 2015 Dec; 79(6):519-29. PubMed ID: 26519128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatology, attribution to medicines, and symptom reporting among Medicare enrollees.
    Oladimeji O; Farris KB; Urmie JG; Doucette WR
    Res Social Adm Pharm; 2009 Sep; 5(3):225-33. PubMed ID: 19733823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positively Framed Risk Information in Patient Information Leaflets Reduces Side Effect Reporting: A Double-Blind Randomized Controlled Trial.
    Webster RK; Weinman J; Rubin GJ
    Ann Behav Med; 2018 Oct; 52(11):920-929. PubMed ID: 30346496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The perceived sensitivity to medicines (PSM) scale: an evaluation of validity and reliability.
    Horne R; Faasse K; Cooper V; Diefenbach MA; Leventhal H; Leventhal E; Petrie KJ
    Br J Health Psychol; 2013 Feb; 18(1):18-30. PubMed ID: 22524270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of factors that contribute to nocebo effects.
    Webster RK; Weinman J; Rubin GJ
    Health Psychol; 2016 Dec; 35(12):1334-1355. PubMed ID: 27657801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No blank slates: Pre-existing schemas about pharmaceuticals predict memory for side effects.
    Heller MK; Chapman SC; Horne R
    Psychol Health; 2017 Apr; 32(4):402-421. PubMed ID: 28219295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of video-based social modelling on the nocebo effect.
    Quinn V; Pearson S; Huynh A; Nicholls K; Barnes K; Faasse K
    J Psychosom Res; 2023 Feb; 165():111136. PubMed ID: 36610337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No(cebo) Vax: COVID-19 Vaccine Beliefs Are Important Determinants of Both Occurrence and Perceived Severity of Common Vaccines' Adverse Effects.
    Mattarozzi K; Bagnis A; Kłosowska J; Bąbel P; Cremonini V; De Palma A; Fabbri A; Farinella E; Puccini L; Sambri V; Semprini S; Russo PM
    Psychol Sci; 2023 May; 34(5):603-615. PubMed ID: 37027171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health complaints and wind turbines: The efficacy of explaining the nocebo response to reduce symptom reporting.
    Crichton F; Petrie KJ
    Environ Res; 2015 Jul; 140():449-55. PubMed ID: 25981871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Placebo and nocebo : How can they be used or avoided?].
    Hansen E; Zech N; Meissner K
    Internist (Berl); 2017 Oct; 58(10):1102-1110. PubMed ID: 28702702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceived sensitivity to medicines: a study among chronic medicine users in Norway.
    Svensberg K; Nordeng H; Gaffari S; Faasse K; Horne R; Lupattelli A
    Int J Clin Pharm; 2019 Jun; 41(3):804-812. PubMed ID: 31028593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does precautionary information about electromagnetic fields trigger nocebo responses? An experimental risk communication study.
    Boehmert C; Verrender A; Pauli M; Wiedemann P
    Environ Health; 2018 Apr; 17(1):36. PubMed ID: 29650009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of Side Effect Information Framing on Nocebo Effects.
    Faasse K; Huynh A; Pearson S; Geers AL; Helfer SG; Colagiuri B
    Ann Behav Med; 2019 Jun; 53(7):621-629. PubMed ID: 30204841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beliefs about medicines and non-adherence in patients with stroke, diabetes mellitus and rheumatoid arthritis: a cross-sectional study in China.
    Wei L; Champman S; Li X; Li X; Li S; Chen R; Bo N; Chater A; Horne R
    BMJ Open; 2017 Oct; 7(10):e017293. PubMed ID: 28982826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.